Complexa, Inc. Initiates First Clinical Trial of CXA-10 for Acute Kidney Injury MarketWatch Complexa also continues its work on oral chronic treatments and intends to file an IND with the FDA for oral administration of CXA-10 in the treatment of chronic kidney disease later this year. Development programs in other inflammatory ... |
